Quipt Home Medical Corp. (QIPT)
NASDAQ: QIPT · IEX Real-Time Price · USD
3.840
-0.010 (-0.26%)
At close: Apr 24, 2024, 4:00 PM
3.838
-0.002 (-0.05%)
After-hours: Apr 24, 2024, 5:01 PM EDT

Company Description

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States.

The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.

It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions.

The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021.

Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

Quipt Home Medical Corp.
Quipt Home Medical logo
Country United States
Founded 1993
Industry Medical Devices
Sector Healthcare
Employees 1,200
CEO Gregory J. Crawford

Contact Details

Address:
1019 Town Drive
Wilder, Kentucky 41076
United States
Phone 859-878-2220
Website quipthomemedical.com

Stock Details

Ticker Symbol QIPT
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001540013
CUSIP Number 74880P104
ISIN Number CA74880P1045
SIC Code 8090

Key Executives

Name Position
Gregory J. Crawford Chairman, President and Chief Executive Officer
Hardik Mehta Chief Financial Officer
David Bachelder Executive Vice President of Operations
William Todd Zehnder Chief Strategy Officer and Investor Relations
Cole Stevens Vice President of Corporate Development and VP of Investor Relations
Mark Miles Vice President of Information Technology
Thomas W. Roehrig Executive Vice President of Finance
Robert Grossman LLB Corporate Secretary

Latest SEC Filings

Date Type Title
Apr 12, 2024 S-8 Securities to be offered to employees in employee benefit plans
Apr 12, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Apr 2, 2024 40-F/A Filing
Mar 28, 2024 6-K Report of foreign issuer
Mar 26, 2024 F-10/A Filing
Mar 13, 2024 6-K Report of foreign issuer
Feb 28, 2024 6-K Report of foreign issuer
Feb 15, 2024 6-K Report of foreign issuer
Feb 14, 2024 6-K Report of foreign issuer
Feb 7, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals